Literature DB >> 14579159

Gout in systemic lupus erythematosus and overlap syndrome - a hospital-based study.

H H Ho1, J L Lin, Y J J Wu, K H Yu, J Y Chen, S F Luo.   

Abstract

The negative association between gout and rheumatoid arthritis is widely accepted, and gout is also speculated to be rare in systemic lupus erythematosus (SLE), as only a few sporadic cases have been reported. From 1985 to 2001 we encountered 15 lupus patients at Chang-Gung Memorial Hospital, including two with lupus-scleroderma and one with lupus-scleroderma-polymyositis overlap syndrome coexisting with gout. This study retrospectively analyses the clinical and laboratory characteristics of these patients. A lower female predominance is found, and most patients developed gout after the onset of SLE, although gout preceded SLE in two cases. Measurement of serum uric acid and 24-h urine uric acid found all of the patients to be hyperuricaemic and underexcretors of uric acid. Furthermore, most of the patients (14/15) were receiving diuretics. Also, many had hypertension and serious cardiovascular diseases. Renal impairment during gouty attacks seemed to be a predisposing factor for developing end-stage renal disease. Gouty arthritis usually occurred during relative SLE inactivity, podagra was frequent, and tophi were found in a few patients. Compared with the unselected population of SLE patients, the cases studied here had a higher incidence of chronic arthritis, malar rash, haematologic disorder, photosensitivity, serositis and neurologic disorder. Renal disease in the patients sampled was frequently membranous nephropathy.

Entities:  

Mesh:

Year:  2003        PMID: 14579159     DOI: 10.1007/s10067-003-0735-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  2 in total

1.  Association of serum uric acid with lupus nephritis in systemic lupus erythematosus.

Authors:  Zaixing Yang; Yan Liang; Weihua Xi; Ye Zhu; Chang Li; Renqian Zhong
Journal:  Rheumatol Int       Date:  2010-02-14       Impact factor: 2.631

2.  Coexisting ankylosing spondylitis and gouty arthritis.

Authors:  Huei-Huang Ho; Kuang-Hui Yu; Ji-Yih Chen; Ja-Liang Lin; Yeong-Jian Jan Wu; Shue-Fen Luo; Lieh-Bang Liou
Journal:  Clin Rheumatol       Date:  2007-03-14       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.